期刊文献+

晕痣 被引量:4

Halo nevus
暂未订购
导出
摘要 晕痣以色素痣绕以圆形或椭圆形局限性色素减退为特征,中心痣大多是后天性痣细胞痣。CD8+为主的T细胞清除痣细胞是发病机制中的关键环节。晕痣与白癜风、黑素瘤在抗原及免疫反应模式方面密切相关。尽管目前认为,对晕痣患者进行随访是最好的治疗策略,但手术切除有助于平息晕痣的免疫活动,因此对于单发皮损,手术切除也许更为合适。 Halo nevus(HN) is characterized by a pigmented nevus surrounding by round or oval local depigmentation. The central nevus is usually an acquired nevocyte nevus. It plays a key role in the pathogenesis of HN that cytotoxic CD8+ T cells eliminate central nevus. HN is closely correlated with vitiligo and melanoma in antigens and immune response pattern. Though clinical follow-up is commonly considered as the optimal treatment for HN presently, surgical resection could help to subside immunological activity in HN, so surgical resection may be more appropriate for single lesion of HN.
作者 周晖 韩建德
出处 《国际皮肤性病学杂志》 2007年第6期355-357,共3页 International Journal of Dermatology and Venereology
关键词 痣色素 白癜风 黑素瘤 Nevus pigmented Vitiligo Melanoma
  • 相关文献

参考文献16

  • 1Mooney MA, Barr RJ, Buxton MG. Halo nevus or halo phenomenon? A study of 142 cases. J Cutan Pathol, 1995, 22(4): 34342-34348.
  • 2Bayer-Garner IB, Ivan D, Schwartz MR, et al. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus. Clin Med Res, 2004, 2 (2): 89-97.
  • 3de Vijlder HC, Westerhof W, Schreuder GM, et al. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res, 2004, 17(3): 270-274.
  • 4Gupta S, Gupta S, Mahendra A, et al. Inverse halo nevus. Dermatol Surg, 2006, 32(6): 871-872.
  • 5Hapif TP. Nevi and Malignant Melanoma. In: Habif TP, eds. Clinical Dermatology: a color guide to diagnosis and therapy. 4th ed. Philadelphia: Mosby, 2004: 781.
  • 6Halo nevus. In:James WD, Berger TG, Elston DM, eds. Andrews' diseases of the skin: clinical dermatology.10th ed. Saunders: Elsevier, 2006 : 689-690.
  • 7Bergman W, Willemze R, de Graaff-Reitsma C, et al. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. J Invest Dermatol, 1985,85( 1 ): 25-29.
  • 8Moretti S, Spallanzani A, Pinzi C, et al. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment? J Cutan Pathol, 2007, 34(4): 301-308.
  • 9Hu Z, Liu JB, Ma SS, et al. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol, 2006, 23(2): 114-116.
  • 10Dogra S, Parsad D, Handa S,et al. Late onset vitiligo: a study of 182 patients. Int J Dermatol, 2005, 44(3 ): 193-196.

同被引文献18

  • 1梁思,刘跃华,左亚刚,王宝玺,方凯.疣状表皮发育不良患者皮损中朗格汉斯细胞CD1a和CD83表达[J].中国医学科学院学报,2009,31(1):17-19. 被引量:2
  • 2胡亚莹,窦小军,曹爱华.冷冻、二氧化碳激光治疗28例晕痣临床观察[J].中国麻风皮肤病杂志,2006,22(3):254-254. 被引量:3
  • 3常建民,鲍迎秋,傅裕.晕痣80例临床分析[J].临床皮肤科杂志,2006,35(9):557-559. 被引量:11
  • 4胡小华,董平.树突状细胞在口腔鳞癌中的浸润度研究[J].合肥医学院学报,2006,29(3):232-234. 被引量:2
  • 5BAYER-GARNER IB,IVAN D,SCHWARTZ MR,et al.The immunopathology of regression in benign lichenoid keratosis,keratoacanthoma and halo nevus[J].Clin Med Res,2004,2(2):89-97.
  • 6SHIMIZU M,SAITOH Y,ITOH H.Immunohistohistochemical staining of Ha-ras oncogene product in normal,benign,and malignant human pancreatic tissues[J].Hum,1990,21(6):607-612.
  • 7GARCIA RL,COLTRERA MD,GOWN AM.Analysis of prolif erative grade using anti-PCNA/cyclin monoclonal antibodies in fixed,embedded tissues.Comparison with flow cytometric analysis[J].Am J Pathol,1989,134(4):733-739.
  • 8HENGR R E,SIELING PA,OCHOA MT,et al.Langerhans cells utilize CD1a ang langerin to efficiently present nonpeptide antigens to T cells[J].Clin Invest,2004,113(5):701-708.
  • 9ZeffRA, Freitag A, Grincm, et al. The immune response in halo nevi. J Am Acad Dermatol, 1997, 37 (4): 620-624.
  • 10Ortonne JP,Mosher DB,Fitzpatrick TB.Vitiligo and other hypomelanoses of hair and skin [M].New York:Plenum Publishing Corporation, 1983:567-611.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部